Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

por Jernström S, Hongisto V, Leivonen SK, Due EU, Tadele DS, Edgren H, Kallioniemi O, Perälä M, Mælandsmo GM, Sahlberg KK
Publicado 2017